Clinical Trials Browser

Phase 2 × Multiple Myeloma × pidilizumab × Clear all

NCT01067287 2026-04-06

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

Phase 2 Completed

Multiple Myeloma